Chemotherapy is not routinely used to treat ACC of the breast; however, in mixed cases, it is likely that to be used on the basis of hormone receptor negativity and the more aggressive potential of the non-ACC component. This evidence concerns the gene NR4A1 and adrenal cortex carcinoma.